Deciphering the molecular morphology of the human hair cycle: Wnt signalling during the telogen–anagen transformation

Citations Over TimeTop 10% of 2019 papers

Abstract

We provide the first evidence that key changes in Wnt signalling that drive murine anagen induction also occur in human scalp HFs, yet with notable differences. This provides a rational basis for Wnt-targeting therapeutic interventions to manipulate human hair growth disorders. What's already known about this topic? Upregulation of Wnt agonists and downregulation of Wnt antagonists in the secondary hair germ and/or dermal papilla drives hair growth (anagen) induction in mice. Autocrine Wnt signalling in murine epithelial hair follicle stem cells is required to maintain their stem cell function. Reduction of Wnt ligands or increased expression of Wnt antagonists induces dysregulation of the murine hair follicle cycle and causes alopecia. What does this study add? This study demonstrates for the first time that key Wnt pathway regulatory agonists, antagonists and target genes, are expressed in the human telogen-to-early-anagen transformation. On human anagen induction the Wnt ligands WNT3, WNT4 and WNT10B are increased in the regenerating epithelium, whereas the Wnt antagonist, SFRP1 (secreted frizzled-related protein 1), is reduced. Human anagen induction has fundamental differences in the expression of Wnt ligands compared with the murine system. What is the translational message? Regulation of these Wnt ligands permits targeted therapeutic interventions in human hair growth disorders and informs development of new drugs that promote or suppress anagen induction.

Related Papers

• → Treatment of Hair Loss(1999)429 cited
• → Induction of Anagen in Telogen Mouse Skin by Topical Application of FK506, a Potent Immunosuppressant(1995)46 cited
• Establishment of Hair Cycle Animal Model with C57BL6 Mice(1999)
• [Cycle of hair growth and evaluation of alopecia].(1997)
• → Targeting human hair follicles(2000)1 cited